News

We are today happy to announce that we are one of six Swedish companies selected as finalists in the 2021 Smart Industry company competition.  yearly competition instituted by Siemens, Teknikföretagen, and the Royal Swedish Academy of Engineering...

𝐓𝐨𝐝𝐚𝐲 𝐰𝐞 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞 𝐚𝐧𝐝 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐬𝐡𝐚𝐫𝐞 𝐭𝐡𝐞 𝐒𝐚𝐢𝐧𝐭 𝐋𝐮𝐜𝐢𝐚 𝐭𝐫𝐚𝐝𝐢𝐭𝐢𝐨𝐧 𝐚𝐭 𝐕𝐢𝐫𝐨𝐧𝐨𝐯𝐚 𝐰𝐢𝐭𝐡 𝐚𝐥𝐥 𝐨𝐮𝐫 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬, 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬, 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬, 𝐚𝐧𝐝 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬...

Video from last weeks OXY Talks where Vironova's CEO and founder Mohammed Homman shares his entrepreneurial journey with Susanna Balsvik and Emma Vallin from OXY Group. Who together from different views and experiences explore the challenges and...

September 15, 2021 We are delighted and honored for the recognition we got at SwedenBIO´s Executive Dinner and BIO-Gala, where our CEO Mohammed Homman received the “Top Talent Creator Award” on behalf of Vironova. An award given to those creating...

Shareholders of Vironova AB (publ), 556678-1463, are hereby summoned to our annual general meeting which will be held on June 30, 2021.

April 28, 2021 NPL’s Biometrology laboratory will further increase their electron microscopy capabilities by hosting Vironova’s MiniTEM system through a new partnership between the organizations. 

Together with leading microscopy image processing researchers at Uppsala University, Vironova has recently published a new peer reviewed research article in the area of microscopy imaging and processing. The article investigates if and how some of...

Vironova’s Director Human Resources, Ann Fredriksson, will be one of a handful members of a new task force put together by SwedenBIO. The cross-organizational group will focus on finding solutions to current human resource challenges in the Nordic...

Vironova Medical AB, a spin off from Vironova AB, have developed an antiviral drug candidate against SARS-CoV-2. A novel class of antiviral drugs against covid-19/SARS-CoV-2, first evaluated in vitro against SARS-CoV-2 virus at the University of...

The SARS-CoV-2 pandemic has had a significant negative impact on the world’s public health and the global economy since its outbreak in the beginning of 2020. From this has the international MAD-CoV 2 project emerged, trying to provide an increased...